InvestorsHub Logo
Post# of 84321
Next 10
Followers 1282
Posts 83691
Boards Moderated 0
Alias Born 07/30/2010

Re: None

Friday, 02/09/2018 9:25:48 AM

Friday, February 09, 2018 9:25:48 AM

Post# of 84321

*** NSAV BLOCKCHAIN NEWS OUT 2-9-2017 ***

Nsav to Develop and Deploy Blockchain for Its Clinical Research Business
Published: Feb 9, 2018 9:20 a.m. ET


NSAV subsidiary to deply Blockchain Technology to clinical research
Cresco, PA, Feb 09, 2018 (GLOBE NEWSWIRE via COMTEX) --

Net Savings Link, Inc. NSAV, +0.00% a medical technology and software company, announced today that its subsidiary, Shanghai based Vital Strategic Research Institute (VSRI), will develop and deploy Blockchain Technology to maximize the quality of its clinical research. The Company believes that Blockchain will provide it with a significant advantage over the competition. VSRI is a medical research firm with a long history of expertise in design, clinical trials and global research. VSRI has collaborated with pharmaceutical giants such as Pfizer and Bristol-Myers Squibb.

In December, VSRI signed a major agreement with Eli Lilly and Company (www.lilly.com ). Under the terms of the agreement, VSRI will provide Eli Lilly with an assessment of Cardio Vascular Disease (CVD) among newly diagnosed diabetes patients at increased risk of CVD in China. China is facing the largest diabetes epidemic in the world with around 11 percent of its population suffering from the metabolic illness, while nearly 36 percent are pre-diabetic. CVD in China has also reached epidemic proportions, with over 200 million Chinese suffering from the world's leading cause of death.

James Tilton, president of NSAV stated, "I am truly pleased that we will be adding Blockchain Technology to our clinical research business. It took a while, but the medical community is finally waking up to the benefits of Blockchain in clinical research and clinical trials and I am thrilled that NSAV will be at the forefront of this revolution."

NSAV's vision is the establishment of a fully integrated technology and software company that provides turnkey technological and software solutions to the medical industry. Over time, the Company plans to provide a wide range of services such as software solutions, e-commerce, advisory services, financial services, patents and trademarks and information technology.

For further information please contact NSAV at 1 (585) 520-2102 or investorgrowthllc@gmail.com

The NSAV corporate email address is info@nsavholdinginc.com

The NSAV corporate website can be accessed at http://nsavholdinginc.com

The NSAV Twitter account can be accessed at https://twitter.com/NSAV_MJTechCo

The NSAV Facebook account can be accessed at https://www.facebook.com/NSAVHolding
Report TOS
Moderate

Never buy or sell based on anything I post - MY POSTS ARE ALWAYS JUST MY OPINION, regardless whether I include that in my post or not. I am not a financial advisor and anything I post should be considered only my opinion at that time.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.